Search Within

Alfredo Rivas Delgado

Formats
  1. Meeting Abstract (12)
  2. Journal Article (5)
  3. Research Letter (2)
  4. Review (1)
Groups
  1. Department of Medicine (20)
  2. Hematologic Malignancies, Division of (20)
  3. Center for Hematologic Malignancies (19)
  4. Lymphoma (19)
  5. Hematology-Oncology Fellows (18)
  6. GME, Medicine (16)

More Groups

People
  1. Gilles Salles (19)
  2. Maria Palomba (19)
  3. Efrat Luttwak (15)
  4. Jennifer Lue (11)
  5. Lorenzo Falchi (11)
  6. Magdalena Corona De Lapuerta (11)

More People

Years
  1. 2025 (5)
  2. 2024 (10)
  3. 2023 (5)
Publications
  1. Blood (12)
  2. Blood Cancer Journal (2)
  3. Haematologica (2)
  4. Blood Advances (1)
  5. Blood Cancer Discovery (1)
  6. British Journal of Haematology (1)

More Publications

Publishers
  1. American Society of Hematology (13)
  2. Ferrata Storti Foundation (2)
  3. Nature Publishing Group (2)
  4. American Association for Cancer Research (1)
  5. John Wiley & Sons (1)
  6. Landes Bioscience (1)

Results (20)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Outcomes of CD19 CAR-T therapy in central nervous system lymphoma: Insights from a multicentre experience
    Journal Article

    Cassanello, G.; Luttwak, E.; Brown, S.; Devlin, S. M.; Imber, B.; Ip, A.; Leslie, L. A.; Accav, N. G.; Avigdor, A.; Marcus, R.; more...
    British Journal of Haematology (2025)

    Fulltext@MSK | Save
  • CAR T-cell therapy response varies by extranodal disease site in large B-cell lymphoma
    Journal Article

    Luna, A.; Devlin, S. M.; Rejeski, K.; Flynn, J. R.; Corona, M.; Luttwak, E.; Rivas-Delgado, A.; Landego, I.; Cassanello, G.; Gomez-Llobell, M.; more...
    Blood Cancer Journal (2025)

    Fulltext@MSK | Save
  • Dynamics of immune reconstitution and impact on outcomes across CAR-T cell products in large B-cell lymphoma
    Journal Article

    Luan, D.; DeWolf, S.; Fei, T.; Raj, S.; Shah, G. L.; Lareau, C. A.; Alhomoud, M.; Salles, G.; Rivas-Delgado, A.; Rejeski, K.; more...
    Blood Cancer Discovery (2025)

    Fulltext@MSK | Save
  • Rituximab and lenalidomide for the treatment of relapsed or refractory indolent non-Hodgkin lymphoma: Real-life experience
    Journal Article

    Cassanello, G.; Drill, E.; Rivas-Delgado, A.; Okwali, M.; Isgor, I.; Caron, P. C.; Epstein-Peterson, Z.; Ghione, P.; Hamlin, P. A.; Lue, J. K.; more...
    Haematologica (2025)

    Fulltext@MSK | Save
  • Cancer cachexia and weight loss before CAR T-cell therapy for lymphoma are independently associated with poor outcomes
    Journal Article

    Valtis, Y. K.; Devlin, S.; Shouval, R.; Rejeski, K.; Corona, M.; De Abia, A. L.; Rivas-Delgado, A.; Luttwak, E.; Cassanello, G.; Landego, I.; more...
    Blood Advances (2025)

    Fulltext@MSK | Save
  • CAR T-cell therapy for DLBCL with CNS involvement: Overall safe and effective with limited efficacy in patients with leptomeningeal disease
    Meeting Abstract

    Luttwak, E.; Cassanello, G.; Brown, S.; Devlin, S. M.; Imber, B. S.; Ip, A.; Leslie, L. A.; Accav, N. G.; Beyar-Katz, O.; Corona, M.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Comparative real-world outcomes of commercial CD19-directed CAR T-cell therapies in large B-cell lymphoma
    Meeting Abstract

    Deschè‚nes-Simard, X.; Bromberg, M.; Devlin, S. M.; Katz, O. B.; Ip, A.; Marcus, R.; Avigdor, A.; Ballweg, A.; Rabinovich, E.; Alhomoud, M.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • When can we define cure after CAR-T therapy in LBCL? insights from serial landmark analyses
    Meeting Abstract

    Gomez-Llobell, M.; Shouval, R.; Brown, S.; Accav, N. G.; Devlin, S. M.; Corona, M.; Rejeski, K.; Rivas-Delgado, A.; Luna, A.; Luttwak, E.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Patterns of immune reconstitution and their clinical significance in aggressive lymphoma treated with CAR-T therapy
    Meeting Abstract

    Luan, D. Y.; Dewolf, S.; Fei, T.; Raj, S. S.; Shah, G. L.; Lareau, C.; Alhomoud, M.; Salles, G.; Rivas-Delgado, A.; Rejeski, K.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • High grade B-cell lymphoma with MYC/BCL6-rearrangements (R) may have inferior outcomes compared to BCL2-R disease
    Meeting Abstract

    Healton, S. E.; Luttwak, E.; Rivas-Delgado, A.; Boardman, A. P.; Caron, P.; David, K. A.; Epstein-Peterson, Z. D.; Falchi, L.; Ghione, P.; Hamlin, P. A.; more...
    Blood (2024)

    Fulltext@MSK | Save